Anna Schmidt

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization

K. Überla, A. Ensser, C. Thirion, 2021, Nature Communications.

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic RNA-mucosal adenoviral vector immunization

K. Überla, A. Ensser, C. Thirion, 2021, bioRxiv.

Effect of mucosal adjuvant IL-1β on heterotypic immunity in a pig influenza model

C. Thirion, M. Tenbusch, W. Gerner, 2023, Frontiers in Immunology.

Evaluation of adenoviral vector Ad19a encoding RSV-F as novel vaccine against respiratory syncytial virus

D. Lapuente, Jana Fuchs, C. Maier, 2024, NPJ vaccines.